Ignite Creation Date:
2025-12-24 @ 5:02 PM
Ignite Modification Date:
2025-12-27 @ 5:11 AM
Study NCT ID:
NCT03924050
Status:
UNKNOWN
Last Update Posted:
2022-12-27
First Post:
2019-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-08
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-18
First Submit QC Date:
None
Study First Post Date:
2019-04-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-23
Last Update Post Date:
2022-12-27
Last Update Post Date Type:
ACTUAL